ArticleThe European respiratory journal2025
Survival benefit of tofacitinib in interstitial lung disease associated with anti-MDA5-positive dermatomyositis: a need for further validation.
Chih-Wei Tseng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.